U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
4326143261Long Term Follow up of Recipients of Functional Islet AllograftsRecruitingNo Results AvailableType 1 Diabetes Mellitushttps://ClinicalTrials.gov/show/NCT01999374
4326243262Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft LossRecruitingNo Results AvailableType 1 Diabetes MellitusDrug: Myfortichttps://ClinicalTrials.gov/show/NCT01999361
4326343263A Study of GANFORT® UD in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) in a Medical SettingCompletedNo Results AvailableGlaucoma, Primary Open Angle|Ocular HypertensionDrug: Fixed Combination Bimatoprost and Timololhttps://ClinicalTrials.gov/show/NCT01999348
4326443264A Study of Oprozomib, Pomalidomide, and Dexamethasone in Subjects With Primary Refractory or Relapsed and Refractory Multiple MyelomaActive, not recruitingNo Results AvailableMultiple MyelomaDrug: Oprozomib|Drug: Pomalidomide|Drug: Dexamethasonehttps://ClinicalTrials.gov/show/NCT01999335
4326543265A Trial Evaluating Compatibility and Safety of FIAsp and Insulin Aspart With an External Continuous Subcutaneous Insulin Infusion System in Adult Subjects With Type 1 DiabetesCompletedNo Results AvailableDiabetes|Diabetes Mellitus, Type 1Drug: Faster-acting insulin aspart|Drug: insulin asparthttps://ClinicalTrials.gov/show/NCT01999322
4326643266Simvastatin Addition for Patients With Recent-onset SchizophreniaRecruitingNo Results AvailableSchizophrenia|Schizoaffective Disorder|Schizophreniform Disorder|Psychosis NOSDrug: Simvastatin|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01999309
4326743267Prospective Evaluation of the Use of Thunderbeat Vessel Sealing Device in Laparoscopic SurgeryActive, not recruitingNo Results AvailableIndication for Laparoscopic Surgery (Any)Device: Use of Thunderbeat (TM) in laparoscopic surgeryhttps://ClinicalTrials.gov/show/NCT01999296
4326843268Effect of Group Pilates and Yoga Exercise Classes for Chronic Cervical PainCompletedNo Results AvailableCervical PainOther: Yoga Group Exercise|Other: Pilates Group Mat Exercisehttps://ClinicalTrials.gov/show/NCT01999283
4326943269Evaluation of FDOPA-PET/MRI in Pediatric Patients With CNS TumorsRecruitingNo Results AvailableAstrocytoma, Oligoastrocytoma, Mixed|Ganglioneuroma|Glioma|Ganglioglioma|Glioblastoma Multiforme GliomaDrug: Irinotecan|Drug: Bevacizumab|Device: FDOPA-PET/MRI imaginghttps://ClinicalTrials.gov/show/NCT01999270
4327043270Efficacy Study of an Online Educational Module Before Carrier Genetic Screening in Persons of Ashkenazi Jewish Descent.Active, not recruitingNo Results AvailableTay Sachs Disease|Canavan Disease|Familial DysautonomiaOther: Online pre-test genetic education toolhttps://ClinicalTrials.gov/show/NCT01999257
4327143271Impact of Self-Monitoring Technology and Interventionist Contact on Weight LossCompletedNo Results AvailableOverweight|ObesityBehavioral: Self-monitoring skills|Behavioral: Technology|Behavioral: Interventionist Contacthttps://ClinicalTrials.gov/show/NCT01999244
4327243272Phase I Clinical Human Tolerability Study of Recombinant Mycobacterium Tuberculosis Allergen ESAT6-CFP10CompletedHas ResultsHealthyBiological: ESAT6-CFP10https://ClinicalTrials.gov/show/NCT01999231
4327343273Ertugliflozin vs. Glimepiride in Type 2 Diabetes Mellitus (T2DM) Participants on Metformin (MK-8835-002)Active, not recruitingNo Results AvailableType 2 Diabetes MellitusDrug: Ertugliflozin 5 mg|Drug: Ertugliflozin 10 mg|Drug: Glimerpiride|Drug: Placebo to Ertugliflozin|Drug: Placebo to Glimepiride|Drug: Metformin|Drug: Sitagliptinhttps://ClinicalTrials.gov/show/NCT01999218
4327443274Moving To Business: Promoting Physical Activity and Reducing Sedentary Behavior in Office-based Companies in FinlandEnrolling by invitationNo Results AvailablePhysical Activity|Sedentary Behavior|Work AbilityBehavioral: Physical activity promotionhttps://ClinicalTrials.gov/show/NCT01999205
4327543275Study to Investigate the Safety and Efficacy of Tregalizumab in Subjects (MTX-IR) With Active Rheumatoid ArthritisActive, not recruitingNo Results AvailableRheumatoid ArthritisDrug: Tregalizumab|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01999192
4327643276Post-thrombotic Syndrome & Predictors of Recurrence in Catheter-related ThrombosisRecruitingNo Results AvailableVenous Thrombosis|NeoplasmsDrug: Heparin, Low-Molecular-Weighthttps://ClinicalTrials.gov/show/NCT01999179
4327743277Phenotype/Genotype Correlation in a Family With Early Onset OsteoarthritisRecruitingNo Results AvailableOsteoarthritisRadiation: radiography (X-ray)|Genetic: DNA samplinghttps://ClinicalTrials.gov/show/NCT01999166
4327843278Evaluation of the Analgesic Effect of Ropivacaine in Topical Use at the Thin Skin Graft Donor SiteRecruitingNo Results AvailableGraft PainDrug: 20 mL topically used during alginate dressing NAROPEINE|Drug: 20 mL topically used during alginate dressing NaClhttps://ClinicalTrials.gov/show/NCT01999153
4327943279Implantable Cardioverter Defibrillator (ICD Registry)RecruitingNo Results AvailableHeart Failure|Nonischemic Cardiomyopathy|Ischemic Cardiomyopathy|Ventricular Arrhythmia|Complications; Device, Cardiachttps://ClinicalTrials.gov/show/NCT01999140
4328043280The Effect of Buprenorphine Delivered by Buprenorphine Transdermal System (BTDS) at Doses up to 80 Micrograms/Hour (Mcg/hr) and Naltrexone on Electrocardiogram (ECG) Intervals in Healthy VolunteersCompletedNo Results AvailableECG EffectsDrug: Buprenorphine transdermal patch|Drug: Naltrexone tablet|Drug: Placebos (for TDS and for naltrexone and for moxifloxacin)|Drug: Moxifloxacin tablethttps://ClinicalTrials.gov/show/NCT01999114
4328143281Safety Pilot Study of Farnesoid X Receptor (FXR) Agonist in Non-alcoholic Fatty Liver Disease (NAFLD) PatientsTerminatedNo Results AvailableNon Alcoholic Fatty Liver DiseaseDrug: Px-104https://ClinicalTrials.gov/show/NCT01999101
4328243282Health Benefits of Functional Meat (With n-3 Fatty Acids and Rosemary Extract) on Low Risk for Cardiovascular Disease PeopleCompletedNo Results AvailableLow Risk for Cardiovascular DiseaseOther: Functional Meet|Other: Control Meathttps://ClinicalTrials.gov/show/NCT01999088
4328343283Stacking Exercises Aid the Decline in FVC and Sick TimeRecruitingNo Results AvailableDuchenne Muscular DystrophyDevice: Lung Volume Recruitment (LVR)https://ClinicalTrials.gov/show/NCT01999075
4328443284Automated Breast Radiation Therapy Using an MR-Guided ProcessActive, not recruitingNo Results AvailableBreast CancerOther: IMRT + CT + MR scanhttps://ClinicalTrials.gov/show/NCT01999062
4328543285Observational Study of the Argus® II Retinal Prosthesis SystemRecruitingNo Results AvailableRetinitis Pigmentosahttps://ClinicalTrials.gov/show/NCT01999049
4328643286Save Hearts in Arizona Registry and Education (SHARE) ProjectRecruitingNo Results AvailableOut-of-hospital Cardiac Arresthttps://ClinicalTrials.gov/show/NCT01999036
4328743287Effects of Low Protein Formula on Renal Function, Oxidative Stress and Antioxidant Capacities in CKD PatientsNot yet recruitingNo Results AvailableChronic Renal DiseaseDietary Supplement: Low protein formula grouphttps://ClinicalTrials.gov/show/NCT01999023
4328843288Mental Health Telemetry for Self-Management in Major DepressionRecruitingNo Results AvailableMajor Depressive DisorderDevice: MHThttps://ClinicalTrials.gov/show/NCT01999010
4328943289A Family Intervention for Delirium PreventionRecruitingNo Results AvailableDeliriumBehavioral: Family educational interventionhttps://ClinicalTrials.gov/show/NCT01998997
4329043290Efficacy and Safety of Ingenol Mebutate Gel 0.06% When Applied Once Daily for 2, 3 or 4 Consecutive Days to a Treatment Area of Approximately 250 cm2 on Trunk and Extremities in Subjects With Actinic KeratosisCompletedNo Results AvailableActinic KeratosisDrug: ingenol mebutatehttps://ClinicalTrials.gov/show/NCT01998984

* Görseller ve İçerik tekif hakkına sahip olabilir